The results of our current ambispective cohort study show that Ki-67 was an independent risk factor for HCC recurrence after LT and the importance of IRF-1 in HCC recurrence has been demonstrated in patients with HCC beyond the Milan criteria. This evidence concerns the gene MKI67 and hepatocellular carcinoma.